Said Salah Dahbour

Said Salah Dahbour

Auto-generated profile, based on publicly available information

Said Salah Dahbour

Jordan University Hospital

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2017 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
SDSaid Dahbour
Said Dahbour
FJFatima Jamali
Fatima Jamali
DADana Alhattab
Dana Alhattab
Ali Al-RadaidehAli Al-Radaideh
Ali Al-Radaideh
OAOsama Ababneh
Osama Ababneh
AAAbdalla Awidi
Abdalla Awidi
Summary: Aims: This open‐label prospective phase I/IIa clinical study used autologous bone marrow‐derived mesenchymal stromal cells (BM‐MSCs) followed by mesenchymal stromal cells conditioned media (MSC‐CM) for the first time to treat multiple sclerosis (MS) patients. The primary goal was to assess the safety and feasibility and the secondary was efficacy. The correlation between the MSC‐CM content and treatment outcome was investigated.Methods: Ten MS patients who failed conventional therapy were enrolled. Adverse events were recorded to assess safety. The Expanded Disability Status Scale (EDSS) was the primary efficacy measurement, the secondary included clinical (25WFT, 9‐PHT), cognitive (MMS), ophthalmology (OCT, VEP), and radiological (MRI lesion and volume) tests. The MSCs‐CM concentration of 27 inflammatory biomarkers was investigated.Results: The treatment protocol was well tolerated by patients. There was an overall trend of improvement in all the tests, except the lesion volume which increased significantly. A decrease of 4 and 3.5 points on the EDSS was achieved in two patients. We report a correlation between a decreased lesion number at baseline and higher IL‐6, IL‐8, and VEGF MSC‐CM content.Conclusion: The used protocol was safe and feasible with possible efficacy. The addition of MSC‐CM could be related to the magnitude of EDSS improvement observed.

21 February 2018 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
NKNahla Khawaja
Nahla Khawaja
JAJawad Ahmad Abu-Shennar
Jawad Ahmad Abu-Shennar
MSMOHAMMAD SALEH
MOHAMMAD SALEH
SDSaid S. Dahbour
Said S. Dahbour
Yousef KhaderYousef Khader
Yousef Khader
KAKamel Ajlouni
Kamel Ajlouni
Peripheral neuropathy is one of the most common microvascular complication of diabetes mellitus. This study is conducted to determine the prevalence of diabetic peripheral neuropathy (DPN) and its associated factors among patients with type 2 diabetes mellitus in Jordan. A cross-sectional study was conducted at the National Center for Diabetes, Endocrinology and Genetics, Jordan. A total of 1003 patients with type 2 diabetes were recruited. Data were collected from participants during a face-to-face structured interview. DPN was assessed using the translated version of Michigan Neuropathy Screening Instrument (MNSI). The overall prevalence of DPN based on MNSI was 39.5%. The most frequently reported symptoms were numbness (32.3%) and pain with walking (29.7%), while the least reported symptoms were the history of amputation (1.3%) and loss of sensation in legs/feet while walking (3.8%). Logistic regression analysis revealed that unemployment, cardiovascular disease, dyslipidemia, diabetic retinopathy and long standing DM (diabetes of ≥ 5 years) were significantly associated with DPN. Peripheral Neuropathy is highly prevalent among Jordanian patients with type 2 diabetes mellitus. DPN was significantly associated with duration of DM, dyslipidemia, diabetic retinopathy, cardiovascular disease, and unemployment. Early detection and appropriate intervention are mandatory among high-risk groups.

1 August 1990 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
ATAla U. Toukan
Ala U. Toukan
ZSZiad K. Sharaiha
Ziad K. Sharaiha
OAOmayma A. Abu-El-Rub
Omayma A. Abu-El-Rub
MHMunther K. Hmoud
Munther K. Hmoud
SDSaed S. Dahbour
Saed S. Dahbour
JMJames E. Maynard
James E. Maynard
In 1985, the authors studied the epidemiology of hepatitis B virus (HBV) in a healthy Middle Eastern population. Residents of three remote villages and urban areas of Jordan were assessed for seroprevalence of hepatitis B surface antigen (HBsAg) and HBV infection. Infection was defined as the presence of antibody to hepatitis B core antigen (total) and/or antibody to hepatitis B surface antigen, with or without HBsAg. The overall HBsAg prevalence was 9.9% and was not age-related, although significant differences were noted between the villages (range, 5.7%–12.8%). The prevalence of HBV infection was 36% and increased with age. In addition, there were differences between the villages in patterns of age-specific infection. A newly constructed socioeconomic index showed greater HBsAg prevalence in lower (14.4%) than in upper (2.4%) socioeconomic groups. A history of contact with a jaundiced person and socioeconomic status were independent risk factors for HBsAg-positive status, while contact with a jaundiced person, rural background, and age were independently related to HBV infection. There was evidence of familial clustering of HBV in two of the villages, with HBV carriers and infected children particularly aggregating around HBsAg-positive siblings. There was also a trend toward an association of HBsAg-positive children with HbsAg-positive mothers. HBV carrier prevalence correlated with family size, and HBV infection in the household Increased proportionately with the number of carriers In the family. Hepatitis B e antigen was detected most frequently in children and antibody to hepatitis B e antigen in adults. Postnatal early childhood transmission through contact among children of poorer and larger families probably accounts for the high endemictty of HBV in this region.

8 February 2014 in Current Treatment Options in Neurology
Verified
Journal Article
Closed access
PDF file
KEKhalid El-Salem
Khalid El-Salem
AYAhmed Yassin
Ahmed Yassin
KAKefah Al-Hayk
Kefah Al-Hayk
SYSalma Yahya
Salma Yahya
DADuha Al-Shorafat
Duha Al-Shorafat
SDSaid S. Dahbour
Said S. Dahbour


22 January 2009 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
SDSaid S. Dahbour
Said S. Dahbour
AWAyman Wahbeh
Ayman Wahbeh
MHMohammad Z. Hamdan
Mohammad Z. Hamdan